Your browser doesn't support javascript.
loading
FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury.
Lee, Bohm; Oh, Yeonsoo; Cho, Eunhye; DiAntonio, Aaron; Cavalli, Valeria; Shin, Jung Eun; Choi, Hae Woong; Cho, Yongcheol.
Affiliation
  • Lee B; Department of Life Sciences, Korea University, Seoul, Republic of Korea.
  • Oh Y; Department of Life Sciences, Korea University, Seoul, Republic of Korea.
  • Cho E; Department of Life Sciences, Korea University, Seoul, Republic of Korea.
  • DiAntonio A; Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA; Needleman Center for Neurometabolism and Axonal Therapeutics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Cavalli V; Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri, USA; Center of Regenerative Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri,
  • Shin JE; Department of Molecular Neuroscience, Dong-A University College of Medicine, Busan, Republic of Korea; Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Republic of Korea.
  • Choi HW; Department of Life Sciences, Korea University, Seoul, Republic of Korea. Electronic address: haewoongchoi@korea.ac.kr.
  • Cho Y; Department of Life Sciences, Korea University, Seoul, Republic of Korea. Electronic address: ycho77@korea.ac.kr.
J Biol Chem ; 298(3): 101647, 2022 03.
Article in En | MEDLINE | ID: mdl-35101451
The dual leucine zipper kinase (DLK) is a key regulator of axon regeneration and degeneration in response to neuronal injury; however, regulatory mechanisms of the DLK function via its interacting proteins are largely unknown. To better understand the molecular mechanism of DLK function, we performed yeast two-hybrid screening analysis and identified FK506-binding protein-like (FKBPL, also known as WAF-1/CIP1 stabilizing protein 39) as a DLK-binding protein. FKBPL binds to the kinase domain of DLK and inhibits its kinase activity. In addition, FKBPL induces DLK protein degradation through ubiquitin-dependent pathways. We further assessed other members in the FKBP protein family and found that FK506-binding protein 8 (FKBP8) also induced DLK degradation. We identified the lysine 271 residue in the kinase domain as a major site of DLK ubiquitination and SUMO3 conjugation and was thus responsible for regulating FKBP8-mediated proteasomal degradation that was inhibited by the substitution of the lysine 271 to arginine. FKBP8-mediated degradation of DLK is mediated by autophagy pathway because knockdown of Atg5 inhibited DLK destabilization. We show that in vivo overexpression of FKBP8 delayed the progression of axon degeneration and suppressed neuronal death after axotomy in sciatic and optic nerves. Taken together, this study identified FKBPL and FKBP8 as novel DLK-interacting proteins that regulate DLK stability via the ubiquitin-proteasome and lysosomal protein degradation pathways.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Axons / MAP Kinase Kinase Kinases / Tacrolimus Binding Proteins / Nerve Degeneration Type of study: Prognostic_studies Language: En Journal: J Biol Chem Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Axons / MAP Kinase Kinase Kinases / Tacrolimus Binding Proteins / Nerve Degeneration Type of study: Prognostic_studies Language: En Journal: J Biol Chem Year: 2022 Type: Article